Bambusa Therapeutics, Inc.

Filed Oct 9, 2026.

About this filing

A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.

period unavailable · Filed Oct 9, 2026

BBTX$15.73-0.8%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EXPERTS

The financial statements as of December 31, 2025 and December 31, 2024 and for the year ended December 31, 2025, and for the period from March 14, 2024 (Inception) through December 31, 2024 included in this prospectus have been so included in reliance on the report (which contains an explanatory paragraph relating to the Company’s ability to continue as a going concern as described in Note 1 to the financial statements) of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.